United States · FDA National Drug Code directory
BUPRENORPHINE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-0950_942860b1-ae08-462f-927a-d611ad05dc40
- Product NDC
- 71335-0950
- Form
- TABLET
- Composition / generic term
- BUPRENORPHINE
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20171025
- Source listing expiry
- 20261231
Source-listed ingredients
- BUPRENORPHINE HYDROCHLORIDE — 2 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET in 1 BOTTLE (71335-0950-1) · 71335-0950-1
- 90 TABLET in 1 BOTTLE (71335-0950-2) · 71335-0950-2
- 30 TABLET in 1 BOTTLE (71335-0950-3) · 71335-0950-3
- 7 TABLET in 1 BOTTLE (71335-0950-4) · 71335-0950-4
- 28 TABLET in 1 BOTTLE (71335-0950-5) · 71335-0950-5
- 1 TABLET in 1 BOTTLE (71335-0950-6) · 71335-0950-6
- 12 TABLET in 1 BOTTLE (71335-0950-7) · 71335-0950-7
- 120 TABLET in 1 BOTTLE (71335-0950-8) · 71335-0950-8
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →